US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.34

+0.07002.14%

Volume:2.61M

Turnover:8.67M

Market Cap:602.91M

PE:-2.32

High:3.40

Open:3.27

Low:3.17

Close:3.27

52wk High:6.94

52wk Low:1.11

Shares:180.51M

Float Shares:99.80M

Volume Ratio:1.80

T/O Rate:2.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4387

EPS(LYR):-1.6516

ROE:-112.34%

ROA:-35.52%

PB:3.73

PE(LYR):-2.02

Loading ...

Overview Company News Filings

Prime Medicine, Inc. Q3 Operating Expenses USD 55.198 Million

THOMSON REUTERS

Prime Medicine Appoints Matthew Hawryluk, Ph.d., M.b.a. as Chief Business Officer

THOMSON REUTERS

Press Release: Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Prime Medicine Showcases Wilson’s Disease Strategy at Virtual KOL Event

H.C. Wainwright Sticks to Its Hold Rating for Prime Medicine, Inc. (PRME)

Prime Medicine, Inc.'s (NASDAQ:PRME) 6.6% loss last week hit both individual investors who own 30% as well as institutions

Simply Wall St.

Septerna Inc. Appoints Biotechnology Veteran Keith Gottesdiener, M.D., to Board of Directors as Chair of Newly Formed R&D Committee

Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today

Prime Medicine Inc. to Participate in Citi's 2025 Biopharma Back to School Conference

Stock Track | Prime Medicine (PRME) Soars 7.08% After Guggenheim Reiterates Buy Rating

Stock Track | Prime Medicine (PRME) Soars 7.08% Following Guggenheim's Buy Rating Reiteration

Chardan Research Adjusts Prime Medicine Price Target to $10 From $12, Maintains Buy Rating

MT Newswires Live

BRIEF-Prime Medicine, Inc. Q2 Operating Expenses USD 54.492 Million

Prime Medicine Q2 EPS $(0.41) Misses $(0.39) Estimate, Sales $1.115M Beat $750.000K Estimate

Prime Medicine Inc. Reports Q2 2025 Results: R&D Expenses Decrease to $41.4M, G&A Expenses Rise to $13.1M Amid Strategic Restructuring

Prime Medicine, Inc. Q2 EPS USD -0.41

THOMSON REUTERS

Prime Medicine, Inc. Q2 Pretax Profit USD -52.591 Million

THOMSON REUTERS

Prime Medicine, Inc. Q2 Net Income USD -52.591 Million

THOMSON REUTERS

Prime Medicine, Inc. Q2 Income From Operations USD -53.377 Million

THOMSON REUTERS

Prime Medicine Inc. Conducted Special Stockholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRME/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRME","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","market":"US","secType":"STK","nameCN":"Prime Medicine, Inc.","latestPrice":3.34,"timestamp":1771880400000,"preClose":3.27,"halted":0,"volume":2607677,"delay":0,"changeRate":0.021406727828746128,"floatShares":99798700,"shares":180510658,"eps":-1.438701,"marketStatus":"Pre-Mkt","change":0.07,"latestTime":"02-24 04:51:02 EST","open":3.27,"high":3.4,"low":3.172,"amount":8665763.885262601,"amplitude":0.069725,"askPrice":3.72,"askSize":100,"bidPrice":2.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.438701,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1666238400000,"exchange":"NASDAQ","adjPreClose":3.34,"postHourTrading":{"tag":"盘后","latestPrice":3.34,"preClose":3.34,"latestTime":"19:43 EST","volume":51383,"amount":170881.4665,"timestamp":1771893812034,"change":0,"changeRate":0,"amplitude":0.014521},"volumeRatio":1.8046677200110997,"impliedVol":1.2641,"impliedVolPercentile":0.676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","floatShares":99798700,"roa":"-35.52%","roe":"-112.34%","lyrEps":-1.651613,"volumeRatio":1.8046677200110997,"shares":180510658,"dividePrice":0,"high":3.4,"amplitude":0.069725,"preClose":3.27,"low":3.172,"week52Low":1.11,"pbRate":"3.73","psRate":"100.87","week52High":6.94,"institutionHeld":0,"latestPrice":3.34,"eps":-1.438701,"divideRate":0,"volume":2607677,"delay":0,"ttmEps":-1.438701,"open":3.27,"prevYearClose":3.47,"prevWeekClose":3.27,"prevMonthClose":3.81,"prevQuarterClose":3.47,"fiveDayClose":3.3,"twentyDayClose":4.43,"sixtyDayClose":3.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRME\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"PRME","fiscalQuarterEnding":"2025/09","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-08-07","symbol":"PRME","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-05-08","symbol":"PRME","fiscalQuarterEnding":"2025/03","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRME\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRME\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.3636,"hold":0.3636,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1752901200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRME\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRME","date":"2026-02-20","current":-2.321539,"percent":0.641533,"low":-12.570387,"twenty":-9.03053,"median":-3.617154,"eighty":-1.964566,"high":-0.737151,"avg":-4.800681,"sd":3.247971,"marketCap":589536912},"quantilePoints":[{"date":"2022-10-21","current":-8.113391,"twenty":-8.464693,"median":-8.289042,"eighty":-8.033081,"marketCap":1341687112},{"date":"2022-10-28","current":-9.601189,"twenty":-8.641295,"median":-8.448017,"eighty":-8.033081,"marketCap":1587719838},{"date":"2022-11-04","current":-10.409439,"twenty":-9.977,"median":-8.685445,"eighty":-8.202968,"marketCap":1721377754},{"date":"2022-11-11","current":-10.872767,"twenty":-10.427972,"median":-9.596041,"eighty":-8.373885,"marketCap":1797996942},{"date":"2022-11-18","current":-11.552132,"twenty":-10.872767,"median":-9.86889,"eighty":-8.458023,"marketCap":1680246066},{"date":"2022-11-25","current":-12.332199,"twenty":-11.490203,"median":-10.239552,"eighty":-8.464693,"marketCap":1793705981},{"date":"2022-12-02","current":-10.349281,"twenty":-11.187493,"median":-10.319508,"eighty":-8.641295,"marketCap":1505292610},{"date":"2022-12-09","current":-10.045591,"twenty":-10.872767,"median":-10.307599,"eighty":-9.081232,"marketCap":1461121193},{"date":"2022-12-16","current":-10.033682,"twenty":-10.868215,"median":-10.164685,"eighty":-9.444687,"marketCap":1459388980},{"date":"2022-12-23","current":-10.617243,"twenty":-10.856622,"median":-10.102289,"eighty":-9.5981,"marketCap":1544267390},{"date":"2022-12-30","current":-11.063846,"twenty":-10.872767,"median":-10.200413,"eighty":-9.61504,"marketCap":1609225356},{"date":"2023-01-06","current":-9.986044,"twenty":-10.872767,"median":-10.254006,"eighty":-9.670445,"marketCap":1452460130},{"date":"2023-01-13","current":-9.503713,"twenty":-10.861386,"median":-10.164685,"eighty":-9.670445,"marketCap":1382305527},{"date":"2023-01-20","current":-9.819312,"twenty":-10.851859,"median":-10.069665,"eighty":-9.588294,"marketCap":1428209156},{"date":"2023-01-27","current":-10.390964,"twenty":-10.806603,"median":-10.07847,"eighty":-9.600159,"marketCap":1511355353},{"date":"2023-02-03","current":-12.570387,"twenty":-10.851859,"median":-10.134912,"eighty":-9.656594,"marketCap":1828350230},{"date":"2023-02-10","current":-11.742683,"twenty":-10.982862,"median":-10.245074,"eighty":-9.675208,"marketCap":1707961465},{"date":"2023-02-17","current":-11.165076,"twenty":-11.402074,"median":-10.277825,"eighty":-9.686245,"marketCap":1623949162},{"date":"2023-02-24","current":-10.140867,"twenty":-11.343717,"median":-10.295689,"eighty":-9.727769,"marketCap":1474978892},{"date":"2023-03-03","current":-9.813358,"twenty":-11.222241,"median":-10.274847,"eighty":-9.713478,"marketCap":1427343050},{"date":"2023-03-10","current":-10.050095,"twenty":-11.104338,"median":-10.254006,"eighty":-9.674017,"marketCap":1224312632},{"date":"2023-03-17","current":-8.918099,"twenty":-11.003108,"median":-10.200413,"eighty":-9.59913,"marketCap":1086411714},{"date":"2023-03-24","current":-8.134409,"twenty":-10.908707,"median":-10.134912,"eighty":-9.535868,"marketCap":990941849},{"date":"2023-03-31","current":-8.925355,"twenty":-10.872767,"median":-10.07847,"eighty":-9.430442,"marketCap":1087295695},{"date":"2023-04-06","current":-8.279537,"twenty":-10.868215,"median":-10.050821,"eighty":-9.350566,"marketCap":1008621453},{"date":"2023-04-14","current":-9.367995,"twenty":-10.856622,"median":-10.045591,"eighty":-9.178488,"marketCap":1141218489},{"date":"2023-04-21","current":-9.716301,"twenty":-10.838758,"median":-10.039636,"eighty":-9.219247,"marketCap":1183649541},{"date":"2023-04-28","current":-9.897711,"twenty":-10.785166,"median":-10.017793,"eighty":-9.345724,"marketCap":1205749047},{"date":"2023-05-05","current":-10.96942,"twenty":-10.785166,"median":-10.021772,"eighty":-9.354933,"marketCap":1336305690},{"date":"2023-05-12","current":-8.073848,"twenty":-10.735146,"median":-10.027727,"eighty":-9.345724,"marketCap":1109169075},{"date":"2023-05-19","current":-8.52077,"twenty":-10.701531,"median":-9.990007,"eighty":-9.099515,"marketCap":1170566377},{"date":"2023-05-26","current":-8.827649,"twenty":-10.681401,"median":-9.975498,"eighty":-9.032416,"marketCap":1212724706},{"date":"2023-06-02","current":-9.637285,"twenty":-10.630075,"median":-9.897711,"eighty":-8.989982,"marketCap":1323950937},{"date":"2023-06-09","current":-9.800518,"twenty":-10.71371,"median":-9.971839,"eighty":-9.02363,"marketCap":1346375580},{"date":"2023-06-16","current":-9.800518,"twenty":-10.686434,"median":-9.86695,"eighty":-9.031944,"marketCap":1346375580},{"date":"2023-06-23","current":-9.767872,"twenty":-10.642906,"median":-9.849086,"eighty":-9.068318,"marketCap":1341890652},{"date":"2023-06-30","current":-9.696049,"twenty":-10.612479,"median":-9.825267,"eighty":-9.106778,"marketCap":1332023809},{"date":"2023-07-07","current":-8.971294,"twenty":-10.602192,"median":-9.819312,"eighty":-9.099515,"marketCap":1232458393},{"date":"2023-07-14","current":-9.545874,"twenty":-10.585619,"median":-9.810202,"eighty":-9.137267,"marketCap":1311393137},{"date":"2023-07-21","current":-9.78093,"twenty":-10.559433,"median":-9.800518,"eighty":-9.17528,"marketCap":1343684623},{"date":"2023-07-28","current":-9.330407,"twenty":-10.517007,"median":-9.791764,"eighty":-9.19176,"marketCap":1281792608},{"date":"2023-08-04","current":-8.977823,"twenty":-10.501721,"median":-9.787459,"eighty":-9.17528,"marketCap":1233355378},{"date":"2023-08-11","current":-7.351426,"twenty":-10.465993,"median":-9.782257,"eighty":-9.044383,"marketCap":1105764783},{"date":"2023-08-18","current":-7.175671,"twenty":-10.456327,"median":-9.761342,"eighty":-8.9726,"marketCap":1079328527},{"date":"2023-08-25","current":-7.708998,"twenty":-10.45472,"median":-9.735225,"eighty":-8.925402,"marketCap":1159548890},{"date":"2023-09-01","current":-8.024145,"twenty":-10.44932,"median":-9.716301,"eighty":-8.912293,"marketCap":1206951832},{"date":"2023-09-08","current":-7.469607,"twenty":-10.444557,"median":-9.701789,"eighty":-8.700407,"marketCap":1123540886},{"date":"2023-09-15","current":-7.660513,"twenty":-10.432557,"median":-9.68952,"eighty":-8.613331,"marketCap":1152256130},{"date":"2023-09-22","current":-6.799918,"twenty":-10.420738,"median":-9.68299,"eighty":-8.464693,"marketCap":1022809634},{"date":"2023-09-29","current":-5.757506,"twenty":-10.409439,"median":-9.671604,"eighty":-8.402895,"marketCap":866015288},{"date":"2023-10-06","current":-5.387814,"twenty":-10.390964,"median":-9.643814,"eighty":-8.183215,"marketCap":810407990},{"date":"2023-10-13","current":-4.030254,"twenty":-10.389027,"median":-9.630354,"eighty":-8.073848,"marketCap":606210701},{"date":"2023-10-20","current":-4.472673,"twenty":-10.38501,"median":-9.604638,"eighty":-7.912615,"marketCap":672757139},{"date":"2023-10-27","current":-3.627229,"twenty":-10.370718,"median":-9.601189,"eighty":-7.834415,"marketCap":545589631},{"date":"2023-11-03","current":-4.018133,"twenty":-10.337372,"median":-9.572309,"eighty":-7.747785,"marketCap":604387511},{"date":"2023-11-10","current":-3.675264,"twenty":-10.30998,"median":-9.557305,"eighty":-7.702937,"marketCap":631311146},{"date":"2023-11-17","current":-3.3021,"twenty":-10.293236,"median":-9.519757,"eighty":-7.529606,"marketCap":567211621},{"date":"2023-11-24","current":-3.898089,"twenty":-10.287686,"median":-9.505205,"eighty":-7.382941,"marketCap":669586402},{"date":"2023-12-01","current":-3.898089,"twenty":-10.280204,"median":-9.486275,"eighty":-7.272639,"marketCap":669586402},{"date":"2023-12-08","current":-4.596094,"twenty":-10.277825,"median":-9.467523,"eighty":-7.212034,"marketCap":789484793},{"date":"2023-12-15","current":-4.977312,"twenty":-10.27187,"median":-9.460993,"eighty":-7.0484,"marketCap":854967761},{"date":"2023-12-22","current":-4.703479,"twenty":-10.257579,"median":-9.4285,"eighty":-6.653253,"marketCap":807930700},{"date":"2023-12-29","current":-5.127651,"twenty":-10.24686,"median":-9.408438,"eighty":-5.953867,"marketCap":880792030},{"date":"2024-01-05","current":-4.837711,"twenty":-10.236142,"median":-9.364366,"eighty":-5.757506,"marketCap":830988083},{"date":"2024-01-12","current":-4.375954,"twenty":-10.18589,"median":-9.353482,"eighty":-5.296906,"marketCap":751670685},{"date":"2024-01-19","current":-3.430962,"twenty":-10.168926,"median":-9.330407,"eighty":-5.123927,"marketCap":589346709},{"date":"2024-01-26","current":-3.586671,"twenty":-10.164237,"median":-9.238996,"eighty":-4.948317,"marketCap":616093273},{"date":"2024-02-02","current":-3.602779,"twenty":-10.145519,"median":-9.172072,"eighty":-4.834489,"marketCap":618860159},{"date":"2024-02-09","current":-3.613518,"twenty":-10.136103,"median":-9.110409,"eighty":-4.737842,"marketCap":620704750},{"date":"2024-02-16","current":-4.188029,"twenty":-10.111093,"median":-9.030058,"eighty":-4.665393,"marketCap":719390349},{"date":"2024-02-23","current":-5.646822,"twenty":-10.09442,"median":-8.977823,"eighty":-4.688731,"marketCap":969971503},{"date":"2024-03-01","current":-5.767109,"twenty":-10.076709,"median":-8.964765,"eighty":-4.703479,"marketCap":990633618},{"date":"2024-03-08","current":-4.732954,"twenty":-10.058794,"median":-8.925355,"eighty":-4.703479,"marketCap":937754463},{"date":"2024-03-15","current":-4.003242,"twenty":-10.050675,"median":-8.921727,"eighty":-4.668042,"marketCap":793174383},{"date":"2024-03-22","current":-4.267799,"twenty":-10.049482,"median":-8.906197,"eighty":-4.583208,"marketCap":845591862},{"date":"2024-03-28","current":-3.930562,"twenty":-10.04768,"median":-8.700407,"eighty":-4.491687,"marketCap":778773976},{"date":"2024-04-05","current":-3.366561,"twenty":-10.043209,"median":-8.6396,"eighty":-4.407369,"marketCap":667026823},{"date":"2024-04-12","current":-3.37819,"twenty":-10.039636,"median":-8.52077,"eighty":-4.327384,"marketCap":669330888},{"date":"2024-04-19","current":-2.668828,"twenty":-10.037254,"median":-8.464693,"eighty":-4.274777,"marketCap":528782922},{"date":"2024-04-26","current":-2.50199,"twenty":-10.028918,"median":-8.446434,"eighty":-4.188029,"marketCap":495726695},{"date":"2024-05-03","current":-3.264437,"twenty":-10.018588,"median":-8.341216,"eighty":-4.102669,"marketCap":646792703},{"date":"2024-05-10","current":-3.328446,"twenty":-10.004291,"median":-8.200833,"eighty":-4.029746,"marketCap":659474913},{"date":"2024-05-17","current":-3.980486,"twenty":-9.988422,"median":-8.1239,"eighty":-4.009198,"marketCap":813997536},{"date":"2024-05-24","current":-3.923945,"twenty":-9.981826,"median":-8.073848,"eighty":-4.003159,"marketCap":802435071},{"date":"2024-05-31","current":-3.675165,"twenty":-9.974034,"median":-7.993843,"eighty":-3.942726,"marketCap":751560225},{"date":"2024-06-07","current":-3.895675,"twenty":-9.959459,"median":-7.880503,"eighty":-3.91716,"marketCap":796653838},{"date":"2024-06-14","current":-4.466739,"twenty":-9.924575,"median":-7.800381,"eighty":-3.915464,"marketCap":913434735},{"date":"2024-06-21","current":-3.477272,"twenty":-9.903084,"median":-7.757482,"eighty":-3.898089,"marketCap":711091597},{"date":"2024-06-28","current":-3.013635,"twenty":-9.891559,"median":-7.748391,"eighty":-3.898089,"marketCap":616279384},{"date":"2024-07-05","current":-3.019289,"twenty":-9.86695,"median":-7.708998,"eighty":-3.890862,"marketCap":617435631},{"date":"2024-07-12","current":-3.39246,"twenty":-9.849086,"median":-7.702937,"eighty":-3.796073,"marketCap":693747900},{"date":"2024-07-15","current":-3.228491,"twenty":-9.847208,"median":-7.681725,"eighty":-3.778891,"marketCap":660216751},{"date":"2024-08-02","current":-2.934478,"twenty":-9.845329,"median":-7.660513,"eighty":-3.769217,"marketCap":600091933},{"date":"2024-08-09","current":-2.348066,"twenty":-9.837082,"median":-7.542333,"eighty":-3.717006,"marketCap":510561109},{"date":"2024-08-16","current":-2.348066,"twenty":-9.830006,"median":-7.412032,"eighty":-3.67956,"marketCap":510561109},{"date":"2024-08-23","current":-2.214349,"twenty":-9.825267,"median":-7.327184,"eighty":-3.673438,"marketCap":481485875},{"date":"2024-08-30","current":-2.305277,"twenty":-9.822885,"median":-7.242337,"eighty":-3.648578,"marketCap":501257034},{"date":"2024-09-06","current":-2.005751,"twenty":-9.819028,"median":-7.218095,"eighty":-3.633092,"marketCap":436128510},{"date":"2024-09-13","current":-2.166211,"twenty":-9.816984,"median":-7.130217,"eighty":-3.604927,"marketCap":471018790},{"date":"2024-09-20","current":-2.09133,"twenty":-9.812096,"median":-7.0484,"eighty":-3.587408,"marketCap":454736659},{"date":"2024-09-27","current":-1.904126,"twenty":-9.805741,"median":-6.757494,"eighty":-3.549424,"marketCap":414031332},{"date":"2024-10-04","current":-1.823896,"twenty":-9.800518,"median":-6.274989,"eighty":-3.530527,"marketCap":396586191},{"date":"2024-10-11","current":-2.096033,"twenty":-9.800518,"median":-5.960905,"eighty":-3.492172,"marketCap":455759414},{"date":"2024-10-18","current":-2.22484,"twenty":-9.799212,"median":-5.781748,"eighty":-3.439553,"marketCap":483766976},{"date":"2024-10-25","current":-2.459034,"twenty":-9.793099,"median":-5.711575,"eighty":-3.388762,"marketCap":534689815},{"date":"2024-10-31","current":-2.382921,"twenty":-9.789539,"median":-5.646223,"eighty":-3.366561,"marketCap":518139892},{"date":"2024-11-08","current":-2.400485,"twenty":-9.787459,"median":-5.509024,"eighty":-3.3021,"marketCap":521959105},{"date":"2024-11-15","current":-2.09217,"twenty":-9.787459,"median":-5.370213,"eighty":-3.228491,"marketCap":458706110},{"date":"2024-11-22","current":-1.728441,"twenty":-9.783584,"median":-5.278724,"eighty":-3.142239,"marketCap":378958872},{"date":"2024-11-29","current":-1.91467,"twenty":-9.781461,"median":-5.127651,"eighty":-3.10297,"marketCap":419789458},{"date":"2024-12-06","current":-1.728441,"twenty":-9.770484,"median":-5.102719,"eighty":-3.019289,"marketCap":378958872},{"date":"2024-12-13","current":-1.751719,"twenty":-9.762648,"median":-4.977312,"eighty":-2.928824,"marketCap":384062695},{"date":"2024-12-20","current":-1.623687,"twenty":-9.755317,"median":-4.917743,"eighty":-2.820996,"marketCap":355991668},{"date":"2024-12-27","current":-1.710982,"twenty":-9.742659,"median":-4.848449,"eighty":-2.756199,"marketCap":375131005},{"date":"2025-01-03","current":-1.74008,"twenty":-9.735225,"median":-4.829657,"eighty":-2.616428,"marketCap":381510784},{"date":"2025-01-10","current":-1.833195,"twenty":-9.734178,"median":-4.773279,"eighty":-2.565592,"marketCap":401926077},{"date":"2025-01-17","current":-1.670244,"twenty":-9.727254,"median":-4.732954,"eighty":-2.515598,"marketCap":366199314},{"date":"2025-01-24","current":-1.897211,"twenty":-9.716301,"median":-4.703479,"eighty":-2.464888,"marketCap":415961590},{"date":"2025-01-31","current":-1.646965,"twenty":-9.716301,"median":-4.693707,"eighty":-2.41225,"marketCap":361095491},{"date":"2025-02-07","current":-1.466556,"twenty":-9.701789,"median":-4.66661,"eighty":-2.388776,"marketCap":321540861},{"date":"2025-02-14","current":-1.510203,"twenty":-9.696049,"median":-4.603473,"eighty":-2.359501,"marketCap":331110530},{"date":"2025-02-21","current":-1.821555,"twenty":-9.690826,"median":-4.563729,"eighty":-2.345927,"marketCap":399374165},{"date":"2025-02-28","current":-1.408359,"twenty":-9.68952,"median":-4.504816,"eighty":-2.315869,"marketCap":308781303},{"date":"2025-03-07","current":-1.498993,"twenty":-9.68887,"median":-4.469706,"eighty":-2.293509,"marketCap":293625746},{"date":"2025-03-14","current":-1.120986,"twenty":-9.684133,"median":-4.454492,"eighty":-2.239982,"marketCap":219580992},{"date":"2025-03-21","current":-1.30999,"twenty":-9.677717,"median":-4.359151,"eighty":-2.207085,"marketCap":256603369},{"date":"2025-03-28","current":-1.303472,"twenty":-9.67349,"median":-4.342349,"eighty":-2.186856,"marketCap":255326736},{"date":"2025-04-04","current":-1.049295,"twenty":-9.670909,"median":-4.327425,"eighty":-2.138978,"marketCap":205538022},{"date":"2025-04-11","current":-0.762531,"twenty":-9.654364,"median":-4.290045,"eighty":-2.09526,"marketCap":149366140},{"date":"2025-04-17","current":-0.808153,"twenty":-9.646426,"median":-4.267799,"eighty":-2.078568,"marketCap":158302576},{"date":"2025-04-25","current":-1.140538,"twenty":-9.639897,"median":-4.228625,"eighty":-2.052446,"marketCap":223410894},{"date":"2025-05-02","current":-1.134021,"twenty":-9.636803,"median":-4.188029,"eighty":-1.987565,"marketCap":222134260},{"date":"2025-05-09","current":-0.835226,"twenty":-9.629128,"median":-4.164846,"eighty":-1.94144,"marketCap":168724922},{"date":"2025-05-16","current":-0.797262,"twenty":-9.614164,"median":-4.081737,"eighty":-1.913506,"marketCap":161055607},{"date":"2025-05-23","current":-0.778279,"twenty":-9.605765,"median":-4.047395,"eighty":-1.903031,"marketCap":157220950},{"date":"2025-05-30","current":-0.797262,"twenty":-9.603258,"median":-4.028179,"eighty":-1.883244,"marketCap":161055607},{"date":"2025-06-06","current":-0.860536,"twenty":-9.59913,"median":-4.020065,"eighty":-1.858801,"marketCap":173837798},{"date":"2025-06-13","current":-0.923811,"twenty":-9.591899,"median":-4.003172,"eighty":-1.847431,"marketCap":186619990},{"date":"2025-06-20","current":-1.138945,"twenty":-9.580335,"median":-3.987503,"eighty":-1.835478,"marketCap":230079439},{"date":"2025-06-27","current":-1.67678,"twenty":-9.558933,"median":-3.930562,"eighty":-1.823896,"marketCap":338728064},{"date":"2025-07-03","current":-2.017108,"twenty":-9.558933,"median":-3.923945,"eighty":-1.821555,"marketCap":407478093},{"date":"2025-07-11","current":-3.041877,"twenty":-9.557305,"median":-3.906143,"eighty":-1.821555,"marketCap":614492687},{"date":"2025-07-18","current":-2.529493,"twenty":-9.545874,"median":-3.898089,"eighty":-1.823896,"marketCap":510985390},{"date":"2025-07-25","current":-2.821391,"twenty":-9.532816,"median":-3.881639,"eighty":-1.823896,"marketCap":569952094},{"date":"2025-08-01","current":-3.129274,"twenty":-9.506698,"median":-3.822172,"eighty":-1.833195,"marketCap":632147777},{"date":"2025-08-08","current":-3.121347,"twenty":-9.506698,"median":-3.770113,"eighty":-1.833195,"marketCap":622006369},{"date":"2025-08-15","current":-2.394727,"twenty":-9.503713,"median":-3.763857,"eighty":-1.834594,"marketCap":477209285},{"date":"2025-08-22","current":-2.118413,"twenty":-9.49861,"median":-3.717571,"eighty":-1.839014,"marketCap":422146675},{"date":"2025-08-29","current":-2.263149,"twenty":-9.473939,"median":-3.697781,"eighty":-1.844834,"marketCap":450988994},{"date":"2025-09-05","current":-2.236833,"twenty":-9.473939,"median":-3.675264,"eighty":-1.8452,"marketCap":445744936},{"date":"2025-09-12","current":-2.6842,"twenty":-9.468806,"median":-3.674945,"eighty":-1.84957,"marketCap":534893924},{"date":"2025-09-19","current":-3.368408,"twenty":-9.467523,"median":-3.663857,"eighty":-1.850651,"marketCap":671239434},{"date":"2025-09-26","current":-3.434197,"twenty":-9.462299,"median":-3.655092,"eighty":-1.850654,"marketCap":684349579},{"date":"2025-10-03","current":-4.38814,"twenty":-9.460993,"median":-3.653787,"eighty":-1.855309,"marketCap":874446684},{"date":"2025-10-10","current":-5.284236,"twenty":-9.442767,"median":-3.660869,"eighty":-1.861129,"marketCap":1053016218},{"date":"2025-10-17","current":-4.919514,"twenty":-9.422673,"median":-3.674726,"eighty":-1.870086,"marketCap":980336126},{"date":"2025-10-24","current":-4.563273,"twenty":-9.410508,"median":-3.675215,"eighty":-1.873552,"marketCap":909346268},{"date":"2025-10-31","current":-3.689635,"twenty":-9.376084,"median":-3.686003,"eighty":-1.873932,"marketCap":735252094},{"date":"2025-11-07","current":-3.545443,"twenty":-9.362189,"median":-3.687819,"eighty":-1.892555,"marketCap":706518104},{"date":"2025-11-14","current":-2.987432,"twenty":-9.360738,"median":-3.675264,"eighty":-1.898465,"marketCap":589536912},{"date":"2025-11-21","current":-3.310398,"twenty":-9.354933,"median":-3.674945,"eighty":-1.90218,"marketCap":653270633},{"date":"2025-11-28","current":-3.427024,"twenty":-9.347664,"median":-3.668218,"eighty":-1.903031,"marketCap":676285587},{"date":"2025-12-05","current":-3.453938,"twenty":-9.335758,"median":-3.656398,"eighty":-1.903688,"marketCap":681596731},{"date":"2025-12-12","current":-3.830732,"twenty":-9.322572,"median":-3.660869,"eighty":-1.90696,"marketCap":755952738},{"date":"2025-12-19","current":-3.229657,"twenty":-9.289925,"median":-3.656398,"eighty":-1.910596,"marketCap":637337203},{"date":"2025-12-26","current":-3.202743,"twenty":-9.245525,"median":-3.651102,"eighty":-1.912924,"marketCap":632026059},{"date":"2026-01-02","current":-3.11303,"twenty":-9.202702,"median":-3.646895,"eighty":-1.91467,"marketCap":614322248},{"date":"2026-01-09","current":-3.516737,"twenty":-9.184905,"median":-3.645227,"eighty":-1.91684,"marketCap":693989399},{"date":"2026-01-16","current":-3.579536,"twenty":-9.169786,"median":-3.645733,"eighty":-1.928007,"marketCap":706382066},{"date":"2026-01-23","current":-4.194068,"twenty":-9.160644,"median":-3.644722,"eighty":-1.937949,"marketCap":827653173},{"date":"2026-01-30","current":-3.723076,"twenty":-9.128566,"median":-3.645733,"eighty":-1.943768,"marketCap":734708164},{"date":"2026-02-06","current":-2.906691,"twenty":-9.092252,"median":-3.629932,"eighty":-1.946678,"marketCap":573603482},{"date":"2026-02-13","current":-2.978461,"twenty":-9.032416,"median":-3.624392,"eighty":-1.949588,"marketCap":587766531},{"date":"2026-02-20","current":-2.987432,"twenty":-9.03053,"median":-3.617154,"eighty":-1.964566,"marketCap":589536912}],"updateTime":1771923677103},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRME\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581900219","title":"Prime Medicine, Inc. Q3 Operating Expenses USD 55.198 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581900219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581900219?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:00","pubTimestamp":1762516801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nPLX41FCA1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2580356213","title":"Prime Medicine Appoints Matthew Hawryluk, Ph.d., M.b.a. as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580356213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580356213?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:01","pubTimestamp":1762174860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA82GDNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2580135542","title":"Press Release: Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580135542","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580135542?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:01","pubTimestamp":1762174860,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov. 03, 2025  -- Prime Medicine, Inc. , a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer . Dr. Hawryluk will lead Prime's corporate and business development initiatives, corporate strategy, and alliance management functions, advancing the company's efforts to expand the reach of Prime Editing through strategic partnerships and collaborations.Earlier in his career, Dr. Hawryluk held senior roles at Foundation Medicine, where he was instrumental in forging the company's transformative strategic partnership and majority acquisition by Roche/Genentech. His experience also includes business development roles at Thermo Fisher Scientific and work in venture capital and translational science. Dr. Hawryluk holds a Ph.D. in Cell Biology and Protein Biochemistry from the University of Pittsburgh School of Medicine, an M.B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2579714051","title":"Prime Medicine Showcases Wilson’s Disease Strategy at Virtual KOL Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2579714051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579714051?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854509,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. will host a virtual event on November 12, 2025, to discuss its liver disease strategy, with a focus on Wilson's Disease. The company will present its plans to develop Prime Editors for genetic liver diseases, detail the current treatment landscape for Wilson's Disease, and highlight the potential of its Prime Editing platform to provide a durable cure. Prime Medicine also plans to file an investigational new drug application for its Wilson's Disease program in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via GlobeNewswire  on October 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL2xg2sN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","PRME","LU2210150020.SGD","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2577395429","title":"H.C. Wainwright Sticks to Its Hold Rating for Prime Medicine, Inc. (PRME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2577395429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577395429?lang=en_us&edition=fundamental","pubTime":"2025-10-22 22:25","pubTimestamp":1761143125,"startTime":"0","endTime":"0","summary":"In a report released today, Arthur He CFA from H.C. Wainwright maintained a Hold rating on Prime Medicine, Inc.. The company’s shares opened today ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-prime-medicine-inc-prme-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-prime-medicine-inc-prme-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME"],"gpt_icon":0},{"id":"2575223403","title":"Prime Medicine, Inc.'s (NASDAQ:PRME) 6.6% loss last week hit both individual investors who own 30% as well as institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2575223403","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575223403?lang=en_us&edition=fundamental","pubTime":"2025-10-13 18:15","pubTimestamp":1760350521,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by retail investors in Prime Medicine indicates that they collectively have a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prme/prime-medicine/news/prime-medicine-incs-nasdaqprme-66-loss-last-week-hit-both-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prme/prime-medicine/news/prime-medicine-incs-nasdaqprme-66-loss-last-week-hit-both-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TSYW.SI","USJW.SI","BK4139",".IXIC","SQQQ","PRME","TQQQ","MNQmain","NQmain","QID","QLD","USAW.SI","PSQ","NVIW.SI"],"gpt_icon":1},{"id":"2571357727","title":"Septerna Inc. Appoints Biotechnology Veteran Keith Gottesdiener, M.D., to Board of Directors as Chair of Newly Formed R&D Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2571357727","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571357727?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:01","pubTimestamp":1759176068,"startTime":"0","endTime":"0","summary":"Septerna Inc. Appoints Biotechnology Veteran Keith Gottesdiener, M.D., to Board of Directors as Chair of Newly Formed R&D Committee. Septerna Inc. has announced the appointment of Keith Gottesdiener, M.D., to its board of directors. Dr. Gottesdiener will serve as chairperson of a newly formed R&D Committee. He brings over 30 years of experience in biotechnology, including leadership roles at Prime Medicine, Rhythm Pharmaceuticals, and Merck Research Laboratories.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief via GlobeNewswire  on September 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL1rnq6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4139","LU2210150020.SGD","BK4007","IE00BGHQF748.EUR","NDAQ","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","RYTM","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SEPN","LU0314104364.USD","PRME","BK4588","LU2210149790.SGD"],"gpt_icon":0},{"id":"2566793946","title":"Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine  today","url":"https://stock-news.laohu8.com/highlight/detail?id=2566793946","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566793946?lang=en_us&edition=fundamental","pubTime":"2025-09-11 08:45","pubTimestamp":1757551509,"startTime":"0","endTime":"0","summary":"20:44 EDT Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine (PRME) today Published first on TheFly – the ultimate source for real-tim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-231k-shares-of-prime-medicine-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-231k-shares-of-prime-medicine-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME","BK4588","BK4139","BK4544","ARKK","BK4585"],"gpt_icon":0},{"id":"2562735622","title":"Prime Medicine Inc. to Participate in Citi's 2025 Biopharma Back to School Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2562735622","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562735622?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:00","pubTimestamp":1756209644,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. will participate in Citi's 2025 Biopharma Back to School Conference with a fireside chat scheduled for Tuesday, September 2, 2025, at 4:45 p.m. ET in Boston, MA. The company is committed to delivering a new class of differentiated one-time curative genetic therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via GlobeNewswire  on August 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nNDL5DJKdC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0130102774.USD","LU0980610538.SGD","LU1668664300.SGD","BK4139","LU2417539215.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4504","LU1791807156.HKD","BK4112","NDAQ","BK4534","LU0128525689.USD","IE00BSNM7G36.USD","LU0648001328.SGD","BK4585","LU2210150020.SGD","PRME","BK4207","LU2125154778.USD","LU0106831901.USD","LU2456880835.USD","LU0052756011.USD","LU1267930227.SGD","LU0098860793.USD","LU0310800965.SGD","LU0170899867.USD","LU1201861249.SGD","LU2125154935.USD","LU0477156953.USD","IE00BKPKM429.USD","LU1244550221.USD","BK4559","LU1366192091.USD","LU0320765646.SGD","LU0072461881.USD","LU0162691827.USD","LU2095319765.USD","IE00BGHQF748.EUR","LU1244550494.USD","LU2360032135.SGD","LU2462157665.USD","BK4566","LU2210149790.SGD","LU1162221912.USD","LU1244550577.SGD","LU0314104364.USD","LU2236285917.USD","LU0130517989.USD"],"gpt_icon":0},{"id":"1193688388","title":"Stock Track | Prime Medicine (PRME) Soars 7.08% After Guggenheim Reiterates Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1193688388","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193688388?lang=en_us&edition=fundamental","pubTime":"2025-08-13 23:04","pubTimestamp":1755097476,"startTime":"0","endTime":"0","summary":"Shares of Prime Medicine, Inc. (PRME) are soaring 7.08% in Wednesday's intraday trading session, following a bullish analyst report from Guggenheim. The surge comes as investors react positively to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRME"],"gpt_icon":0},{"id":"1152975125","title":"Stock Track | Prime Medicine (PRME) Soars 7.08% Following Guggenheim's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1152975125","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152975125?lang=en_us&edition=fundamental","pubTime":"2025-08-13 23:04","pubTimestamp":1755097466,"startTime":"0","endTime":"0","summary":"Shares of Prime Medicine, Inc. (PRME) are surging 7.08% in Wednesday's intraday trading session, following a positive analyst report from Guggenheim. The biotechnology company's stock price jump...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRME"],"gpt_icon":0},{"id":"2558668386","title":"Chardan Research Adjusts Prime Medicine Price Target to $10 From $12, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2558668386","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558668386?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:29","pubTimestamp":1754915369,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) has an average rating of overweight and mean price target of $7.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME"],"gpt_icon":0},{"id":"2557563914","title":"BRIEF-Prime Medicine, Inc. Q2 Operating Expenses USD 54.492 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557563914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557563914?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:11","pubTimestamp":1754568698,"startTime":"0","endTime":"0","summary":"BRIEF-Prime Medicine, Inc. Q2 Operating Expenses USD 54.492 MillionAug 7 (Reuters) - Prime Medicine Inc PRME.O:PRIME MEDICINE, INC. Q2 OPERATING EXPENSES USD 54.492 MILLIONPRIME MEDICINE, INC. Q2 PRET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX957CCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2557356878","title":"Prime Medicine Q2 EPS $(0.41) Misses $(0.39) Estimate, Sales $1.115M Beat $750.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356878","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557356878?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:09","pubTimestamp":1754568587,"startTime":"0","endTime":"0","summary":"Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by 6.22 percent. This is a 10.87 percent increase over losses of $(0.46) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46959480/prime-medicine-q2-eps-0-41-misses-0-39-estimate-sales-1-115m-beat-750-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2557568735","title":"Prime Medicine Inc. Reports Q2 2025 Results: R&D Expenses Decrease to $41.4M, G&A Expenses Rise to $13.1M Amid Strategic Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568735","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568735?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:01","pubTimestamp":1754568074,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. Reports Q2 2025 Results: R&D Expenses Decrease to $41.4M, G&A Expenses Rise to $13.1M Amid Strategic Restructuring. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via GlobeNewswire  on August 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL1p145F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","LU2095319765.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4139","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2557568545","title":"Prime Medicine, Inc. Q2 EPS USD -0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568545?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX957CCB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2557568533","title":"Prime Medicine, Inc. Q2 Pretax Profit USD -52.591 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568533?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX957CCB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2557568510","title":"Prime Medicine, Inc. Q2 Net Income USD -52.591 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568510?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX957CCB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2557568379","title":"Prime Medicine, Inc. Q2 Income From Operations USD -53.377 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568379?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX957CCB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2557314307","title":"Prime Medicine Inc. Conducted Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2557314307","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557314307?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:24","pubTimestamp":1754425467,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. held a virtual special meeting of stockholders on August 1, 2025. During the meeting, stockholders voted to approve a one-time repricing of certain outstanding stock options held by current employees, including executive officers and board members. Additionally, a proposal to adjourn the meeting to a later date, if necessary, was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL6rgbBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}]}}